Detection of myocardial injury due to defibrillation threshold checking after insertion of implantable cardioverter/defibrillators

Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Acta cardiologica (Impact Factor: 0.65). 04/2013; 68(2):167-72. DOI: 10.2143/AC.68.2.2967274
Source: PubMed


Possible myocardial damage caused by defibrillation threshold (DFT) control and its extent after insertion of implantable cardioverter/defibrillators (ICD) is still a matter for debate. This study aimed to identify the effect of DFT checking during ICD implantation, compared with permanent pacemaker (PPM) implantation, on the magnitude of myocardial damage as assessed by cardiac troponin-T (cTNT) and CK-MB.
A total of 133 candidates for ICD implantation were enrolled in the ICD group (mean age 60.66 +/- 12.25 years; males 111 [83.5%]) as well as 130 candidates in the PPM group (mean age 69.56 +/- 12.86 years; males 64 [49.2%]). DFT was controlled in all of the ICD patients. Serum levels of cTNT and CK-MB were measured at baseline plus 8 and 24 hours following the procedure. The results were adjusted for age, gender, and other confounding factors. The amount of cTNT rise after 8 and 24 hours in the ICD group was significantly higher than in the PPM group (p < 0.001 for both). These differences remained significant after adjustment for confounding factors. The level of CK-MB rise after 8 and 24 hours was also significantly higher in the ICD group, although it lost its significance after adjustment for age, gender and other confounding variables. There was no significant relationship between the amount of energy delivered and enzyme elevation.
Elevation of cTNT and CK-MB after the ICD implantation was significantly higher than that after the PPM implantation and may be attributed to the DFT testing shock and resulting myocardial injury.

Download full-text


Available from: Akbar Shafiee,
  • [Show abstract] [Hide abstract]
    ABSTRACT: Anaesthetic drugs and internal electrical shock may alter haemodynamic status of patients undergoing implantable cardioverter-defibrillator (ICD) testing. Comparative data on the mechanisms of etomidate and propofol-induced changes in haemodynamic parameters are inconsistent. Also the effects of ICD shock on haemodynamics have not been extensively studied.
    Kardiologia polska 05/2014; 72(8). DOI:10.5603/KP.a2014.0086 · 0.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Multiple shocks of the implantable cardioverter defibrillator (ICD) can cause myocardial injury, contributing to the progression of underlying heart disease. The aim was to evaluate if the elevation of troponin I after multiple ICD shocks has impact on the prognostic of these patients. Methods We evaluated patients with multiple ICD shocks (> 3 shocks) in the last 24 hours. Troponin I was measured around 12 hours after the last shock. After this episode, these patients were followed and events of death or heart failure hospitalization were recorded. Results Twenty-six patients were included in the study. Elevation of troponin I occurred in 16 patients (62%), who had received a higher number of shocks (14 ± 9 vs. 7 ± 4, p = 0.03) and greater cumulative total voltage (455 ± 345 J vs. 141 ± 62 J, p = 0.03) compared to the group without elevation of this biomarker. We observed a positive correlation between troponin I and number of shocks (r = 0.70; p = 0.0001). Patients with troponin I elevation after multiple ICD shocks had higher risk of death or heart failure hospitalization (hazard ratio (HR): 7.0; 95% confidence interval (IC) 1.2 to 16.0; p = 0.03) compared with the group without elevation of this biomarker. After adjustment for age, gender and number of shocks, the elevation of this biomarker remained as predictor of these events (HR:16.0; 95% CI 1.7 to 151.0; p = 0.02). Conclusion Large proportion of patients with multiple ICD shocks have troponin I elevation, and these patients have higher risk of death or hospitalization due to heart failure.
    American Journal of Emergency Medicine 09/2014; 32(9). DOI:10.1016/j.ajem.2014.04.053 · 1.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies have reported the defibrillation testing during implantable cardioverter defibrillator (ICD) implantation is associated with elevated cardiac biomarkers and ST-segment electrocardiogram (ECG) changes suggesting that shocks during testing may cause harm. However, the effects of testing have not been isolated from the implant procedure itself, where lead deployment may cause myocardial damage. This prospective study examined high sensitivity troponin T (hs-TnT) levels and ECG changes during ICD implanting alone, ICD implantation with testing and device testing as a stand-alone procedure. We examined hs-TnT at baseline, and 6-8 h post procedure and 12 lead ECG at baseline, and 30 s, 5 min, and 10 min post right ventricle lead deployment and post defibrillation. There was no significant change in hs-TnT levels in a group of patients (n = 11) undergoing defibrillation testing alone, while hs-TnT was significantly elevated in patients undergoing implantation alone (n = 13, median increase 96%, P = 0.005) and in patients undergoing implantation and testing (n = 13, median increase 161%, P = 0.005). There was a significant correlation between the number of lead deployments and the percentage change in hs-TnT (r = -0.51, P = 0.01), but no correlation between either the number of shocks (r = 0.26, P = 0.25) or the total delivered energy (r = 0.24, P = 0.30) and percentage change in hs-TnT. Implantation of ICD leads was associated with release of troponin, but we did not observe any evidence that ICD shocks alone cause myocardial injury. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email:
    Europace 11/2014; 17(2). DOI:10.1093/europace/euu306 · 3.67 Impact Factor
Show more